Corium Reports Second Quarter Fiscal 2016 Financial REsults and REcent Corporate Highlights
MENLO PARK, Calif. , May 10, 2016 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results for the second…